triple agonist glp 1 Beyond GLP-1: Retatrutide's triple-agonist mechanism (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing Retatrutide 40mg | Triple GIP/GLP-1/Glucagon
Description
In comparison to placebo, liraglutide treatment reduced the prevalence of NAFLD by two-thirds, the amount of fat in the liver by 44%, visceral adipose tissue by 18%, and body weight by 5.2 kg (5.6%) (199)
Presented at: 66th Scientific Sessions of the American Diabetes Association
One drug interaction is a major, 26 minor, and 325 moderate
Do GLP-1 medications affect contraception
Both are in the class of drugs known as GLP-1 agonists
There is no safe shortcut
